NOAH website
Compendium home page
Introduction
Presentation
Uses
Dosage and administration
Contra-indications, warnings, etc
Pharmaceutical precautions
Legal category
Packaging Quantities
Further information
Marketing authorisation number
You are here:
Introduction
> Presentation
Depo-Medrone V 40 mg/ml Suspension for Injection: Presentation
Depo-Medrone V 40 mg/ml Suspension for Injection
Presentation
Each ml contains Methylprednisolone Acetate 4.0% w/v plus 0.2 % w/v Myristyl-gamma-picolinium chloride as preservative.
Date updated: 21 September 2007
Powered by the Librios Semantic Environment
Depo-Medrone V 40 mg/ml Suspension for Injection: Presentation
Date updated: 21 September 2007